These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37251926)

  • 1. Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection.
    Chen Z; Xing J; Zheng C; Zhu Q; He P; Zhou D; Li X; Li Y; Qi S; Ouyang Q; Zhang B; Xie Y; Ren J; Cao B; Zhu S; Huang J
    Front Oncol; 2023; 13():1161489. PubMed ID: 37251926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
    Zhu Q; He P; Zheng C; Chen Z; Qi S; Zhou D; Li Y; Ouyang Q; Zi H; Tang H; Xing J; Xie Y; Zhu S; Ren J; Huang J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8369-8378. PubMed ID: 37079049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.
    Li T; Sun G; Ye H; Song C; Shen Y; Cheng Y; Zou Y; Fang Z; Shi J; Wang K; Dai L; Wang P
    Br J Cancer; 2024 Sep; 131(5):883-894. PubMed ID: 38956246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development and validation of predictive models for esophageal squamous cell carcinoma and its precancerous lesions using terminal motif analysis in circulating cell-free DNA].
    Liu SY; Li ZQ; Dou LZ; Zhang YM; Liu Y; Liu YM; Ke Y; Liu XD; Wu HR; Chu JT; He S; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):549-565. PubMed ID: 38880735
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
    Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
    Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
    Chen H; Sun G; Han Z; Wang H; Li J; Ye H; Song C; Zhang J; Wang P
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295640
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
    Wang C; Sun G; Wang H; Dai L; Zhang J; Du R
    BMC Cancer; 2022 Aug; 22(1):932. PubMed ID: 36038839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Cheng L; Ren P; Shi J; Dai L; Wang P; Zhang J
    Oncoimmunology; 2020 Sep; 9(1):1814515. PubMed ID: 33457096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study.
    Fan Z; Qin Y; Zhou J; Chen R; Gu J; Li M; Zhou J; Li X; Lin D; Wang J; Deng D; Wei W
    Cancer Med; 2022 Nov; 11(21):4033-4042. PubMed ID: 35352503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
    Zhou JH; Zhang B; Kernstine KH; Zhong L
    World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and validation of combined biomarkers for the diagnosis of esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma.
    Zheng YQ; Huang HH; Chen SX; Xu XE; Li ZM; Li YH; Chen SZ; Luo WX; Guo Y; Liu W; Li EM; Xu LY
    J Proteomics; 2024 Jul; 304():105233. PubMed ID: 38925350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
    Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
    Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma.
    Wang H; Yang X; Sun G; Yang Q; Cui C; Wang X; Ye H; Dai L; Shi J; Zhang J; Wang P
    Front Oncol; 2021; 11():661043. PubMed ID: 34568004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
    Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
    Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.